Skip to content

Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Visual Function After Implantation of Bilateral AcrySof ReSTOR Aspheric +3

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00719732
Enrollment
218
Registered
2008-07-22
Start date
2007-09-30
Completion date
2009-05-31
Last updated
2010-03-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cataract

Keywords

ReSTOR Aspheric +3 IOL

Brief summary

A prospective evaluation of the visual parameters in a series of patients bilaterally implanted with AcrySof ReSTOR +3 Intraocular Lens (IOL).

Interventions

DEVICEReSTOR

Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).

Sponsors

Alcon Research
Lead SponsorINDUSTRY

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* Diagnosed with cataracts

Exclusion criteria

* Pre-existing conditions that could skew the results or are contraindications for the ReSTOR intraocular lens; * \<1 diopter astigmatism by keratometry readings.

Design outcomes

Primary

MeasureTime frameDescription
Uncorrected Visual Acuity (UCVA)6 monthsUncorrected Visual Acuity (UCVA) measured by means of logMAR at various distances (40 centimeters (cm), 50 cm, 60 cm, 70 cm, and 4 meters (m)). Visual Acuity (VA) is measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution. A lower logMAR value indicates better visual acuity.

Countries

United States

Participant flow

Recruitment details

Subjects 18 - 70 years of age, either sex and any race. Diagnosis of cataracts in one or both eyes.

Pre-assignment details

Subject's eligibility was determined at the preoperative visit. All subjects met inclusion/exclusion criteria.

Participants by arm

ArmCount
ReSTOR Aspheric +3
Enrolled subjects receive implantation of ReSTOR +3 intraocular lenses (IOLs) for replacement of cataract in the natural lens of the eye. The patients were to be implanted bilaterally (in both eyes).
218
Total218

Withdrawals & dropouts

PeriodReasonFG000
Overall StudyIllness not associated with device1
Overall StudyLost to Follow-up20
Overall StudyUnilateral (not bilateral) implantation1

Baseline characteristics

CharacteristicReSTOR Aspheric +3
Age Categorical
<=18 years
0 participants
Age Categorical
>=65 years
64 participants
Age Categorical
Between 18 and 65 years
143 participants
Gender
Female
88 participants
Gender
Male
124 participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 196
serious
Total, serious adverse events
1 / 196

Outcome results

Primary

Uncorrected Visual Acuity (UCVA)

Uncorrected Visual Acuity (UCVA) measured by means of logMAR at various distances (40 centimeters (cm), 50 cm, 60 cm, 70 cm, and 4 meters (m)). Visual Acuity (VA) is measured in logMAR. LogMAR is the logarithm of the minimum angle of resolution. A lower logMAR value indicates better visual acuity.

Time frame: 6 months

ArmMeasureGroupValue (MEAN)Dispersion
ReSTOR Aspheric +3Uncorrected Visual Acuity (UCVA)UCVA at 40 cm0.05 logMARStandard Deviation 0.1
ReSTOR Aspheric +3Uncorrected Visual Acuity (UCVA)UCVA at 50 cm-0.07 logMARStandard Deviation 0.15
ReSTOR Aspheric +3Uncorrected Visual Acuity (UCVA)UCVA at 60 cm0.15 logMARStandard Deviation 0.14
ReSTOR Aspheric +3Uncorrected Visual Acuity (UCVA)UCVA at 70 cm0.20 logMARStandard Deviation 0.13
ReSTOR Aspheric +3Uncorrected Visual Acuity (UCVA)UCVA at 4 m-0.01 logMARStandard Deviation 0.11

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026